Nathan Marko Markarian (Nathan M Markarian, Nathan Markarian)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Tissue Engineering

Cell Cycle Arrest

Hyaluronic Acid

Top Venues

bioRxiv : the preprint server for biology

Pathogens (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Alicia Reyes Valenzuela, Mark Turner, Nathan Marko Markarian, Christophe Lachance-Brais, John Hanrahan, Hojatollah Vali, Silvia Vidal, Luc Mongeau
Design, infectability, and transcriptomic analysis of transregionally differentiated and scalable lung organoids derived from adult bronchial cells. bioRxiv : the preprint server for biology (2024)
Alicia Reyes Valenzuela, Mark Turner, Nathan Marko Markarian, Christophe Lachance-Brais, John Hanrahan, Hojatollah Vali, Silvia Vidal, Luc Mongeau
Design, infectability, and transcriptomic analysis of transregionally differentiated and scalable lung organoids derived from adult bronchial cells. bioRxiv : the preprint server for biology (2024)
Alicia Reyes Valenzuela, Mark Turner, Nathan Marko Markarian, Christophe Lachance-Brais, John Hanrahan, Hojatollah Vali, Silvia Vidal, Luc Mongeau
Design, infectability, and transcriptomic analysis of transregionally differentiated and scalable lung organoids derived from adult bronchial cells. bioRxiv : the preprint server for biology (2024)
Victor H Vázquez-Valadez, Alejandro Hernández-Serda, Ma Fernanda Jiménez-Cabiedes, Pablo Aguirre-Vidal, Ingrid González-Tapia, Laura Carreño-Vargas, Yoshio A Alarcón-López, Andrea Espejel-Fuentes, Pablo Martínez-Soriano, Miguel Lugo Álvarez, Ana María Velázquez-Sánchez, Nathan Marko Markarian, Enrique Angeles, Levon Abrahamyan
Evaluation of Inhibitory Activity In Silico of In-House Thiomorpholine Compounds between the ACE2 Receptor and S1 Subunit of SARS-CoV-2 Spike. Pathogens (Basel, Switzerland) 10 (9) (2021)
Nathan Marko Markarian, Levon Abrahamyan
AMDV Vaccine: Challenges and Perspectives. Viruses 13 (9) (2021)